YH14618

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YH14618, covering 2015-05-29 to 2016-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of YH14618 in Patients With Degenerative Disc Disease [Phase 2]